We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
+8.91%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$1.77B
AUM Growth
+$297M
Cap. Flow
+$195M
Cap. Flow %
11%
Top 10 Hldgs %
25.89%
Holding
186
New
46
Increased
63
Reduced
28
Closed
46

Top Buys

Rank Stock Value
1
CPAY icon
Corpay
CPAY
+$50.4M
2
BMY icon
Bristol-Myers Squibb
BMY
+$40.6M
3
CNC icon
Centene
CNC
+$33.7M
4
CLVT icon
Clarivate
CLVT
+$27.5M
5
BAX icon
Baxter International
BAX
+$23.8M

Top Sells

Rank Stock Value
1
APP icon
Applovin
APP
+$35.3M
2
CRM icon
Salesforce
CRM
+$28.3M
3
FLEX icon
Flex
FLEX
+$21.2M
4
IPGP icon
IPG Photonics
IPGP
+$18.1M
5
LYFT icon
Lyft
LYFT
+$17.6M

Sector Composition

Rank Sector Weight
1 Technology 30.43%
2 Healthcare 14.56%
3 Communication Services 14.3%
4 Consumer Discretionary 11.94%
5 Industrials 8.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CPAY icon
1
Corpay
CPAY
$25.7B
$52.4M 2.96%
+248,424
New +$50.4M
CLVT icon
2
Clarivate
CLVT
$1.37B
$51.4M 2.9%
5,469,638
+2,664,472
+95% +$27.5M
SSNC icon
3
SS&C Technologies
SSNC
$18.9B
$50.6M 2.86%
895,680
+331,537
+59% +$19.1M
DBX icon
4
Dropbox
DBX
$7.78B
$49.3M 2.78%
2,278,113
+815,248
+56% +$17.9M
CMCSA icon
5
Comcast
CMCSA
$87.3B
$46.6M 2.63%
1,227,972
+289,941
+31% +$11M
T icon
6
AT&T
T
$164B
$45.9M 2.59%
2,383,934
+557,446
+31% +$10.7M
EBAY icon
7
eBay
EBAY
$51.2B
$43.5M 2.46%
980,087
+147,803
+18% +$6.77M
CNC icon
8
Centene
CNC
$30.5B
$39.9M 2.25%
631,524
+474,372
+302% +$33.7M
BMY icon
9
Bristol-Myers Squibb
BMY
$129B
$39.9M 2.25%
+575,485
New +$40.6M
META icon
10
Meta Platforms (Facebook)
META
$1.49T
$39M 2.2%
184,145
+71,156
+63% +$12.1M
VTRS icon
11
Viatris
VTRS
$20.8B
$37.5M 2.12%
3,902,910
+1,935,438
+98% +$21.5M
WEX icon
12
WEX
WEX
$6.41B
$36.9M 2.09%
200,747
+97,838
+95% +$17.8M
FTDR icon
13
Frontdoor
FTDR
$5.27B
$36.5M 2.06%
1,307,916
-621,841
-32% -$16.4M
VNT icon
14
Vontier
VNT
$4.54B
$36.3M 2.05%
1,326,599
+33,681
+3% +$814K
CHRD icon
15
Chord Energy
CHRD
$7.69B
$31.8M 1.8%
236,390
+152,399
+181% +$20.7M
WBD icon
16
Warner Bros
WBD
$64.3B
$31.3M 1.77%
2,071,681
-860,440
-29% -$12.2M
IPGP icon
17
IPG Photonics
IPGP
$3.4B
$29.4M 1.66%
238,073
-156,649
-40% -$18.1M
EXEL icon
18
Exelixis
EXEL
$13.9B
$27M 1.53%
1,392,709
+428,622
+44% +$7.47M
ZM icon
19
Zoom
ZM
$27.1B
$26.6M 1.5%
360,127
+7,795
+2% +$562K
APP icon
20
Applovin
APP
$134B
$26.5M 1.5%
1,684,888
-2,691,389
-61% -$35.3M
NOMD icon
21
Nomad Foods
NOMD
$1.78B
$25.7M 1.45%
1,372,344
+511,767
+59% +$9.03M
KGC icon
22
Kinross Gold
KGC
$27.7B
$25.4M 1.43%
5,385,079
+2,698,377
+100% +$11.4M
EGO icon
23
Eldorado Gold
EGO
$8.33B
$24.1M 1.36%
+2,328,114
New +$21.7M
LEVI icon
24
Levi Strauss
LEVI
$9.49B
$23.6M 1.33%
1,295,454
+32,707
+3% +$562K
VZ icon
25
Verizon
VZ
$197B
$23.1M 1.31%
594,354
+264,854
+80% +$10.4M
1
2 3 4 5

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return
SCP
Seizert Capital Partners Birmingham, Michigan $2.17B AUM 11.2% 1-Year Est. Return
OWP
Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
MMLI
Massachusetts Mutual Life Insurance Springfield, Massachusetts $2.17B AUM 48.68% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Invenomic Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Invenomic Capital Management held 186 positions worth $1.77B, up 20% from $1.47B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Invenomic Capital Management deployed $195M of net new capital in Q1 2023, opening 46 new positions and adding to 63 existing holdings. Its largest new stake was Corpay: 248,424 shares worth $52.4M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Applovin, an estimated $35.3M trimmed.

  • Invenomic Capital Management's largest Q1 2023 buy was Corpay: 248,424 shares worth $52.4M.
  • Invenomic Capital Management added most to Centene in Q1 2023, an estimated $33.7M increase.
  • Invenomic Capital Management's biggest Q1 2023 reduction was Applovin, cutting an estimated $35.3M.
  • Invenomic Capital Management fully exited Salesforce in Q1 2023, selling an estimated $28.3M.
  • Invenomic Capital Management's ten largest holdings make up 26% of its $1.77B portfolio in Q1 2023.
  • Invenomic Capital Management opened 46 new positions and closed 46 in Q1 2023.
  • Invenomic Capital Management's portfolio value rose 20% quarter-over-quarter to $1.77B.

Based on Invenomic Capital Management's 13F filing for Q1 2023, filed 15 May 2023.